Fabry disease (FD) clinical manifestations often start in childhood. Among the FD complications, renal failure causes significant morbidity and mortality. Early diagnosis and treatment of FD nephropathy in children may be critical to preserve renal function. In proteinuric progressive nephropathies it has been described that pro-fibrotic miR-21, miR-192, and miR-433 families are activated and that anti-fibrotic miR-29 and miR-200 families are inhibited. Objective: Analyze urinary excretion of microRNAs related to renal fibrosis in FD patients with mild or absent nephropathy. Patients with confirmed diagnosis of FD under 18 years of age were compared with healthy subjects. Patients were classified into two groups: 1) Patients with urinary excretion profile of microRNAs indicative of renal fibrosis; and 2) Patients with urinary excretion profile of microRNAs not indicative of renal fibrosis. Results: 9 healthy subjects were enrolled in the study (18.66 ± 13.43 years), 4 males and 5 females. All of them presented normal eFGR without pathological albuminuria. FD population: 12 patients (10.33 ± 3.93 years) were studied, 5 males and 7 females. Patients presented 2 different genotypes: L415P (6 patients) and E398X (6 patients). The urinary excretion profile of microRNAs indicative of renal fibrosis was present in 4 patients (2 with L415P genotype and 2 with E398X genotype), all of them with a decreased of miR-29 and/or miR-200. No patient presented increased miR-21, miR-192 and/or miR-433. Decreased α -gal-A activity was the only variable associated with statistical significance (p ≤ 0.01) to urinary excretion profile of microRNA indicative of renal fibrosis. Conclusions: Young FD patients with classical mutations of GLA gene and mild or absent nephropathy could present a profile of urinary excretion of microRNAs indicative of renal fibrosis associated with decreased α -gal-A activity independently of the other variables. Our findings could suggest a regulation of microRNAs not mediated by TGF- β in FD nephropathy.
Tsutsumi, O., Sato, M., Sato, K., Mizuno, M. and Sakamoto, S. (1985) Early Prenatal Diagnosis of Inborn Error of Metabolism: A Case Report of a Fetus Affected with Fabry’s Disease. Asia-Oceania Journal of Obstetrics and Gynaecology, 11, 39-45. https://doi.org/10.1111/j.1447-0756.1985.tb00045.x
Hopkin, R.J., Bissler, J., Banikazemi, M., Clarke, L., Eng, C.M., Germain, D.P., Lemay, R., Tylki-Szymanska, A. and Wilcox, W.R. (2008) Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry. Pediatric Research, 64, 550-555. https://doi.org/10.1203/PDR.0b013e318183f132
Waldek, S., Patel, M.R., Banikazemi, M., Lemay, R. and Lee, P. (2009) Life Expectancy and Cause of Death in Males and Females with Fabry Disease: Findings from the Fabry Registry. Genetics in Medicine, 11, 790-796. https://doi.org/10.1097/GIM.0b013e3181bb05bb
Najafian, B., Mauer, M., Hopkin, R.J. and Svarstad, E. (2013) Renal Complications of Fabry Disease in Children. Pediatric Nephrology, 28, 679-687. https://doi.org/10.1007/s00467-012-2222-9
Sheth, K.J., Roth, D.A. and Adams, M.B. (1983) Early Renal Failure in Fabry’s Disease. American Journal of Kidney Diseases, 2, 651-654. https://doi.org/10.1016/S0272-6386(83)80047-X
Tondel, C., Bostad, L., Hirth, A. and Svarstad, E. (2008) Renal Biopsy Findings in Children and Adolescents with Fabry Disease and Minimal Albuminuria. American Journal of Kidney Diseases, 51, 767-776. https://doi.org/10.1053/j.ajkd.2007.12.032
Fogo, A.B., Bostad, L., Svarstad, E., Cook, W.J., Moll, S., Barbey, F., Geldenhuys, L., West, M., Ferluga, D., Vujkovac, B., Howie, A.J., Burns, A., Reeve, R., Waldek, S., Noel, L.H., Grunfeld, J.P., Valbuena, C., Oliveira, J.P., Muller, J., Breunig, F., Zhang, X., Warnock, D.G. and All Members of the International Study Group of Fabry (2010) Scoring System for Renal Pathology in Fabry Disease: Report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrology Dialysis Transplantation, 25, 2168-2177. https://doi.org/10.1093/ndt/gfp528
Perretta, F., Antongiovanni, N. and Jaurretche, S. (2017) Early Renal Involvement in a Girl with Classic Fabry Disease. Case Reports in Nephrology, 2017, Article ID: 9543079. https://doi.org/10.1155/2017/9543079
Trimarchi, H., Canzonieri, R., Schiel, A., Costales-Collaguazo, C., Politei, J., Stern, A., Paulero, M., Rengel, T., Andrews, J., Forrester, M., Lombi, M., Pomeranz, V., Iriarte, R., Muryan, A., Zotta, E., Sanchez-Nino, M.D. and Ortiz, A. (2016) Increased Urinary CD80 Excretion and Podocyturia in Fabry Disease. Journal of Translational Medicine, 14, 289.
Trimarchi, H., Canzonieri, R., Schiel, A., Politei, J., Stern, A., Andrews, J., Paulero, M., Rengel, T., Araoz, A., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Young, P., Muryan, A. and Zotta, E. (2016) Podocyturia Is Significantly Elevated in Untreated vs Treated Fabryadult Patients. Journal of Nephrology, 29, 791-797. https://doi.org/10.1007/s40620-016-0271-z
Aguiar, P., Azevedo, O., Pinto, R., Marino, J., Baker, R., Cardoso, C., Ducla Soares, J.L. and Hughes, D. (2017) New Biomarkers Defining a Novel Early stage of Fabry Nephropathy: A Diagnostic Test Study. Molecular Genetics and Metabolism, 121, 162-169. https://doi.org/10.1016/j.ymgme.2017.05.007
Trionfini, P., Benigni, A. and Remuzzi, G. (2015) MicroRNAs in Kidney Physiology and Disease. Nature Reviews Nephrology, 11, 23-33. https://doi.org/10.1038/nrneph.2014.202
Chung, A.C. and Lan, H.Y. (2015) MicroRNAs in Renal Fibrosis. Frontiers in Physiology, 6, 50. https://doi.org/10.3389/fphys.2015.00050
Aguiar, P., Costa, M.C., Azevedo, O., Fiúza, M., Marino, J., Soares, J.L.D. and Enguita, F.J. (2017) MicroRNAs in Fabry Disease: Role as Biomarkers and a Possible Pathophysiological Pathway. Molecular Genetics and Metabolism, 120, S17.
Aguiar, P., Azevedo, O., Pinto, R., Marino, J., Cardoso, C., Soares, J.L.D. and Hughes, D. (2017) Increase Synthesis of Collagen Type I: An Early Event in Fabry Cardiomyopathy. New Biomarkers? Molecular Genetics and Metabolism, 120, S17-S18.
Pasqualim, G.P.é., Angrezani, J., Giugliani, R., Vairo, F. and Matte, U. (2017) MicroRNA and Gene Expression Studies Provide Novel Information to Understand Heart Disease in Women with Fabry Disease. Molecular Genetics and Metabolism, 120, S106.
Cammarata, G., Scalia, S., Colomba, P., Zizzo, C., Pisani, A., Riccio, E., Montalbano, M., Alessandro, R., Giordano, A. and Duro, G. (2018) A Pilot Study of Circulating MicroRNAs as Potential Biomarkers of Fabry Disease. Oncotarget, 9, 27333-27345. https://doi.org/10.18632/oncotarget.25542
Hopkin, R.J., Jefferies, J.L., Laney, D.A., Lawson, V.H., Mauer, M., Taylor, M.R., Wilcox, W.R. and Fabry, P. (2016) The Management and Treatment of Children with Fabry Disease: A United States-Based Perspective. Molecular Genetics and Metabolism, 117, 104-113. https://doi.org/10.1016/j.ymgme.2015.10.007
Eng, C.M., Resnick-Silverman, L.A., Niehaus, D.J., Astrin, K.H. and Desnick, R.J. (1993) Nature and Frequency of Mutations in the Alpha-Galactosidase A Gene That Cause Fabry Disease. The American Journal of Human Genetics, 53, 1186-1197.
Schirinzi, A., Centra, M., Prattichizzo, C., Gigante, M., De Fabritiis, M., Giancaspro, V., Petrarulo, F., Santacroce, R., Margaglione, M., Gesualdo, L. and Ranieri, E. (2008) Identification of GLA Gene Deletions in Fabry Patients by Multiplex Ligation-Dependent Probe Amplification (MLPA). Molecular Genetics and Metabolism, 94, 382-385. https://doi.org/10.1016/j.ymgme.2008.03.017
Li, Y., Scott, C.R., Chamoles, N.A., Ghavami, A., Pinto, B.M., Turecek, F. and Gelb, M.H. (2004) Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening. Clinical Chemistry, 50, 1785-1796. https://doi.org/10.1373/clinchem.2004.035907
Peralta, C.A., Shlipak, M.G., Judd, S., Cushman, M., McClellan, W., Zakai, N.A., Safford, M.M., Zhang, X., Muntner, P. and Warnock, D. (2011) Detection of Chronic Kidney Disease with Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association with Progression to End-Stage Renal Disease and Mortality. JAMA, 305, 1545-1552. https://doi.org/10.1001/jama.2011.468
Tondel, C., Ramaswami, U., Aakre, K.M., Wijburg, F., Bouwman, M. and Svarstad, E. (2010) Monitoring Renal Function in Children with Fabry Disease: Comparisons of Measured and Creatinine-Based Estimated Glomerular Filtration Rate. Nephrology Dialysis Transplantation, 25, 1507-1513. https://doi.org/10.1093/ndt/gfp658
Chen, C., Ridzon, D.A., Broomer, A.J., Zhou, Z., Lee, D.H., Nguyen, J.T., Barbisin, M., Xu, N.L., Mahuvakar, V.R., Andersen, M.R., Lao, K.Q., Livak, K.J. and Guegler, K.J. (2005) Real-Time Quantification of microRNAs by Stem-Loop RT-PCR. Nucleic Acids Research, 33, e179.
Bustin, S.A., Beaulieu, J.F., Huggett, J., Jaggi, R., Kibenge, F.S., Olsvik, P.A., Penning, L.C. and Toegel, S. (2010) MIQE Precis: Practical Implementation of Minimum Standard Guidelines for Fluorescence-Based Quantitative Real-Time PCR Experiments. BMC Molecular Biology, 11, 74. https://doi.org/10.1186/1471-2199-11-74
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J. and Wittwer, C.T. (2009) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clinical Chemistry, 55, 611-622. https://doi.org/10.1373/clinchem.2008.112797
Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F. and Vandesompele, J. (2009) A Novel and Universal Method for microRNA RT-qPCR Data Normalization. Genome Biology, 10, R64.
Livak, K.J. and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta DeltaC(T)) Method. Methods, 25, 402-408. https://doi.org/10.1006/meth.2001.1262
Ramaswami, U., Whybra, C., Parini, R., Pintos-Morell, G., Mehta, A., Sunder-Plassmann, G., Widmer, U., Beck, M. and F.O.S.E. Investigators (2006) Clinical Manifestations of Fabry Disease in Children: Data from the Fabry Outcome Survey. Acta Paediatrica, 95, 86-92. https://doi.org/10.1080/08035250500275022
Laney, D.A., Peck, D.S., Atherton, A.M., Manwaring, L.P., Christensen, K.M., Shankar, S.P., Grange, D.K., Wilcox, W.R. and Hopkin, R.J. (2015) Fabry Disease in Infancy and Early Childhood: A Systematic Literature Review. Genetics in Medicine, 17, 323-330. https://doi.org/10.1038/gim.2014.120
Liguori, R., Di Stasi, V., Bugiardini, E., Mignani, R., Burlina, A., Borsini, W., Baruzzi, A., Montagna, P. and Donadio, V. (2010) Small Fiber Neuropathy in Female Patients with Fabry Disease. Muscle & Nerve, 41, 409-412. https://doi.org/10.1002/mus.21606
Biegstraaten, M., Hollak, C.E., Bakkers, M., Faber, C.G., Aerts, J.M. and van Schaik, I.N. (2012) Small Fiber Neuropathy in Fabry Disease. Molecular Genetics and Metabolism, 106, 135-141. https://doi.org/10.1016/j.ymgme.2012.03.010
Zar-Kessler, C., Karaa, A., Sims, K.B., Clarke, V. and Kuo, B. (2016) Understanding the Gastrointestinal Manifestations of Fabry Disease: Promoting Prompt Diagnosis. Therapeutic Advances in Gastroenterology, 9, 626-634. https://doi.org/10.1177/1756283X16642936
Seydelmann, N., Wanner, C., Stork, S., Ertl, G. and Weidemann, F. (2015) Fabry Disease and the Heart. Best Practice & Research: Clinical Endocrinology & Metabolism, 29, 195-204. https://doi.org/10.1016/j.beem.2014.10.003
Tuttolomondo, A., Pecoraro, R., Simonetta, I., Miceli, S., Arnao, V., Licata, G. and Pinto, A. (2013) Neurological Complications of Anderson-Fabry Disease. Current Pharmaceutical Design, 19, 6014-6030. https://doi.org/10.2174/13816128113199990387
Schiffmann, R., Warnock, D.G., Banikazemi, M., Bultas, J., Linthorst, G.E., Packman, S., Sorensen, S.A., Wilcox, W.R. and Desnick, R.J. (2009) Fabry Disease: Progression of Nephropathy, and Prevalence of Cardiac and Cerebrovascular Events before Enzyme Replacement Therapy. Nephrology Dialysis Transplantation, 24, 2102-2111. https://doi.org/10.1093/ndt/gfp031
Jaurretche, S., Antogiovanni, N. and Perreta, F. (2017) Prevalence of Chronic Kidney Disease in Fabry Disease Patients: Multicenter Cross Sectional Study in Argentina. Molecular Genetics and Metabolism, 12, 41-43. https://doi.org/10.1016/j.ymgmr.2017.05.007
Schiffmann, R., Waldek, S., Benigni, A. and Auray-Blais, C. (2010) Biomarkers of Fabry Disease Nephropathy. Clinical Journal of the American Society of Nephrology, 5, 360-364. https://doi.org/10.2215/CJN.06090809
Meng, X.M., Tang, P.M., Li, J. and Lan, H.Y. (2015) TGF-Beta/Smad Signaling in Renal Fibrosis. Frontiers in Physiology, 6, 82. https://doi.org/10.3389/fphys.2015.00082
Bottinger, E.P. (2007) TGF-Beta in Renal Injury and Disease. Seminars in Nephrology, 27, 309-320. https://doi.org/10.1016/j.semnephrol.2007.02.009